
Overview
Background
Professor Mark Schembri is a prominent microbiologist with experience in combating the global health crisis presented by multi-drug resistant pathogens. Professor Schembri’s expertise on the virulence of bacterial pathogens and his innovative analysis of biofilm formation aims to improve the outcomes of the >400 million individuals that suffer from urinary tract infections each year across the globe.
Through the application of genetic, genomic and functional studies on uropathogenic E. coli, Professor Schembri has identified targets to reduce the virulence of this pathogen, and will pursue the development of life-saving therapeutic and preventative advances with the assistance of NHMRC, MRFF and ARC grants. Professor Schembri has tracked the rapid emergence and global spread of a virulent, drug-resistant E. coli clone and used genome sequencing to understand its evolution and virulence.
Links: Professor Schembri collaborates with national and international research leaders, including in Denmark, where he was a lecturer. Professor Schembri has strong links with other international experts in his field, including at the Pasteur Institute and the Wellcome Trust Sanger Institute in Cambridge. His research collaborations also span lead groups at UQ and other top Australian institutes, including Griffith and La Trobe Universities.
Membership, Funding and patents: Since 2014, Professor Schembri has been awarded over $15 million in funding from competitive national research funding bodies. He holds provisional patents for the development of novel therapeutic agents and vaccine antigens. He is a Fellow of the American Academy of Microbiology, and is regularly invited to speak at international conferences in his field.
Awards and Communication: Professor Schembri was the recipient of the Frank Fenner Award (2010) and the ASM BacPath Oration Award (2019) for his outstanding original research contribution to the study of Infectious Disease. He was an Australian Research Council Future Fellow (2011-2015) a National Health and Medical Research Council Senior Research Fellow (2016-2020). Professor Schembri is the author of >240 peer-reviewed research manuscripts. He is President of the Australian Society for Microbiology (2022-2026).
Availability
- Professor Mark Schembri is:
- Available for supervision
Fields of research
Qualifications
- Doctor of Philosophy, Monash University
Research impacts
Professor Schembri’s outstanding original work in the field of infectious disease and multi-drug resistant pathogens has led to several key advances in the fight to reduce the prevalence and improve outcomes of urinary tract infections.
Key research outputs: The genomic epidemiology of the most widespread antibiotic resistant uropathogenic E. coli clone allowed its origin and dissemination to be mapped on a global scale. Recent work in Professor Schembri’s group has defined the virulence of this pathogen using advanced genetic, transcriptomic and proteomic methods in conjunction with mouse models of infection. He has also led the use of new treatments to prevent infection by this antibiotic resistant pathogen.
Key capabilities: Professor Schembri has deep expertise in microbiology, with particular capability in the study of antibiotic resistant Gram-negative bacterial pathogens and high-throughput modelling of drug-resistant biofilms, as well as the application of forefront technologies to examine virulence, genomic epidemiology, host-pathogen interactions and novel strategies for the treatment/prevention of infectious diseases.
Works
Search Professor Mark Schembri’s works on UQ eSpace
1998
Journal Article
The prevalence of Helicobacter pylori in practising dental staff and dental students
Lin, SK, Lambert, JR, Schembri, MA, Nicholson, L and Johnson, IH (1998). The prevalence of Helicobacter pylori in practising dental staff and dental students. Australian Dental Journal, 43 (1), 35-39. doi: 10.1111/j.1834-7819.1998.tb00150.x
1996
Journal Article
The origin and fate of herniated lumbar intervertebral disc tissue
Moore, Robert J., Vernon-Roberts, Barrie, Fraser, Robert D., Osti, Orso L. and Schembri, Mark (1996). The origin and fate of herniated lumbar intervertebral disc tissue. Spine, 21 (18), 2149-2155. doi: 10.1097/00007632-199609150-00018
1996
Journal Article
Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract
Connell, H., Agace, W., Schembri, M. and Marild, S. (1996). Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proceedings of the National Academy of Sciences of the United States of America, 93 (18), 9827-9832. doi: 10.1073/pnas.93.18.9827
1996
Journal Article
The Escherichia coli K-12 gntP gene allows E-coli F-18 to occupy a distinct nutritional niche in the streptomycin-treated mouse large intestine
Sweeney, Neal J., Klemm, Per, McCormick, Beth A., Moller-Nielsen, Eva, Utley, Maryjane, Schembri, Mark A., Laux, David C. and Cohen, Paul S. (1996). The Escherichia coli K-12 gntP gene allows E-coli F-18 to occupy a distinct nutritional niche in the streptomycin-treated mouse large intestine. Infection and Immunity, 64 (9), 3497-3503. doi: 10.1128/IAI.64.9.3497-3503.1996
1996
Journal Article
Linker insertion analysis of the FimH adhesin of type 1 fimbriae in an Escherichia coli fimH-null background
Schembri, Mark A., Pallesen, Lars, Connell, Hugh, Hasty, David L. and Klemm, Per (1996). Linker insertion analysis of the FimH adhesin of type 1 fimbriae in an Escherichia coli fimH-null background. FEMS Microbiology Letters, 137 (2-3), 257-263. doi: 10.1111/j.1574-6968.1996.tb08115.x
1996
Conference Publication
Fimbriae-mediated adherence induces mucosal inflammation and bacterial clearance: consequences for anti-adhesion therapy
Connell, H., Agace, W., Hedlund, M., Klemm, P., Shembri, M. and Svanborg, C. (1996). Fimbriae-mediated adherence induces mucosal inflammation and bacterial clearance: consequences for anti-adhesion therapy. Bat-Sheva Seminar on Towards Anti-Adhesion Therapy of Microbial Infectious Diseases, Ichron Yaakov, Israel, 25 February - 1 March 1996. New York, United States: Springer.
1996
Conference Publication
The FIMH protein of type 1 fimbriae - an adaptable adhesin
Klemm, P., Schembri, M. and Hasty, D. L. (1996). The FIMH protein of type 1 fimbriae - an adaptable adhesin. Bat-Sheva Seminar on Towards Anti-Adhesion Therapy of Microbial Infectious Diseases, Ichron Yaakov, Israel, 25 February - 1 March 1996. New York, United States: Springer.
1995
Journal Article
High prevalence of helicobacter-pylori antibodies in an institutionalized population: Evidence for person-to-person transmission
Lambert, J.R., Lin, S.K., Sievert, W., Nicholson, L., Schembri, M. and Guest, C. (1995). High prevalence of helicobacter-pylori antibodies in an institutionalized population: Evidence for person-to-person transmission. American Journal of Gastroenterology, 90 (12), 2167-2171.
1995
Journal Article
Identification of a 13-kDa protein associated with the polyhydroxyalkanoic acid granules from Acinetobacter spp.
Schembri, Mark A., Woods, Alan A., Bayly, Ronald C. and Davies, John K. (1995). Identification of a 13-kDa protein associated with the polyhydroxyalkanoic acid granules from Acinetobacter spp.. FEMS Microbiology Letters, 133 (3), 277-283. doi: 10.1111/j.1574-6968.1995.tb07897.x
1995
Journal Article
Phosphate concentration regulates transcription of the Acinetobacter polyhydroxyalkanoic acid biosynthetic genes
Schembri, Mark A., Bayly, Ronald C. and Davies, John K. (1995). Phosphate concentration regulates transcription of the Acinetobacter polyhydroxyalkanoic acid biosynthetic genes. Journal of Bacteriology, 177 (15), 4501-4507. doi: 10.1128/jb.177.15.4501-4507.1995
1994
Journal Article
Helicobacter pylori prevalence in endoscopy and medical staff
Lin, Shao K., Lambert, John R., Schembri, Mark A., Nicholson, Lesley and Korman, Melvyn G. (1994). Helicobacter pylori prevalence in endoscopy and medical staff. Journal of Gastroenterology and Hepatology, 9 (4), 319-324. doi: 10.1111/j.1440-1746.1994.tb01249.x
1994
Journal Article
Cloning and analysis of the polyhydroxyalkanoic acid synthase gene from an Acinetobacter sp.: Evidence that the gene is both plasmid and chromosomally located
Schembri, Mark A., Bayly, Ronald C. and Davies, John K. (1994). Cloning and analysis of the polyhydroxyalkanoic acid synthase gene from an Acinetobacter sp.: Evidence that the gene is both plasmid and chromosomally located. FEMS Microbiology Letters, 118 (1-2), 145-152. doi: 10.1016/0378-1097(94)90610-6
1993
Journal Article
Comparison of commercial diagnostic tests for Helicobacter pylori antibodies
Schembri, M. A. and Lambert, J. R. (1993). Comparison of commercial diagnostic tests for Helicobacter pylori antibodies. Journal of Clinical Microbiology, 31 (10), 2621-2624. doi: 10.1128/JCM.31.10.2621-2624.1993
1992
Journal Article
Ribotyping of Helicobacter pylori from clinical specimens
Tee, Wee, Lambert, John, Smallwood, Richard, Schembri, Mark, Ross, Bruce C. and Dwyer, Brian (1992). Ribotyping of Helicobacter pylori from clinical specimens. Journal of Clinical Microbiology, 30 (6), 1562-1567. doi: 10.1128/JCM.30.6.1562-1567.1992
1992
Journal Article
A comparison of diagnostic-tests to determine helicobacter-pylori infection
Lin, S.K., Lambert, J.R., Schembri, M., Nicholson, L., Finlay, M., Wong, C. and Coulepis, A. (1992). A comparison of diagnostic-tests to determine helicobacter-pylori infection. Journal of Gastroenterology and Hepatology, 7 (2), 203-209. doi: 10.1111/j.1440-1746.1992.tb00963.x
1991
Conference Publication
Microbiological and genetic aspects of the synthesis of polyphosphate by species of Acinetobacter
Bayly, R. C., Duncan, A., May, J. W., Schembri, M., Semertjis, A., Vasiliadis, G. and Raper, W. G. C. (1991). Microbiological and genetic aspects of the synthesis of polyphosphate by species of Acinetobacter. 15Th Biennial Conf of the International Assoc On Water Pollution Research and Control, Kyoto, Japan, 29 July-3 August 1990. London, United Kingdom: IWA Publishing. doi: 10.2166/wst.1991.0525
Funding
Current funding
Past funding
Supervision
Availability
- Professor Mark Schembri is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Diversity, regulation and function of the uropathogenic Escherichia coli capsule
Principal Advisor
Other advisors: Professor Matt Sweet, Dr Duy Phan
-
Doctor Philosophy
Understanding virulence factors and their regulation in uropathogenic Escherichia coli (UPEC)
Principal Advisor
Other advisors: Dr Nhu Nguyen
-
Doctor Philosophy
How bacteria form antibiotic resistant biofilms
Principal Advisor
Other advisors: Dr Nhu Nguyen, Dr Duy Phan
-
Doctor Philosophy
Microbial effects on host mitochondrial DNA
Associate Advisor
Other advisors: Associate Professor Steven Zuryn
-
Doctor Philosophy
Application of Transposon Directed Insertion Site Sequencing to Enhance Understanding of Essential Genes in Escherichia coli
Associate Advisor
Other advisors: Professor Ian Henderson
-
Doctor Philosophy
Identifying new targets for treatment of antimicrobial resistant infections
Associate Advisor
Other advisors: Professor Ian Henderson
-
Doctor Philosophy
Boosting innate immune defence to combat antibiotic-resistant bacterial infections
Associate Advisor
Other advisors: Dr Divya Ramnath, Professor Matt Sweet
-
Doctor Philosophy
Application of Transposon Directed Insertion Site Sequencing to Enhance Understanding of Essential Genes in Escherichia coli
Associate Advisor
Other advisors: Professor Ian Henderson
-
Doctor Philosophy
Genomic and molecular characterisation of antibiotic resistance mechanisms
Associate Advisor
Other advisors: Dr Brian Forde
Completed supervision
-
2024
Doctor Philosophy
Understanding virulence factors and their regulation in uropathogenic Escherichia coli (UPEC)
Principal Advisor
Other advisors: Dr Nhu Nguyen
-
2024
Doctor Philosophy
Understanding antibiotic resistance and virulence in uropathogenic Escherichia coli
Principal Advisor
Other advisors: Dr Duy Phan
-
2023
Doctor Philosophy
Understanding the regulation of biofilm matrix components in uropathogenic Escherichia coli virulence
Principal Advisor
Other advisors: Dr Nhu Nguyen
-
2023
Doctor Philosophy
Virulence and Resistance Plasmids of Extra-intestinal Pathogenic Escherichia coli
Principal Advisor
Other advisors: Dr Duy Phan
-
2022
Doctor Philosophy
Characterisation of Escherichia coli fimbrial and autotransporter adhesins
Principal Advisor
Other advisors: Dr Duy Phan
-
2019
Doctor Philosophy
Molecular characterisation of A/C plasmids
Principal Advisor
Other advisors: Dr Duy Phan
-
2018
Doctor Philosophy
Molecular and genomic analysis of multidrug resistant Uropathogenic Escherichia coli
Principal Advisor
Other advisors: Associate Professor Scott Beatson
-
2017
Doctor Philosophy
Characterisation of flagella and resistance to oxidative stress in Escherichia coli ST131 virulence
Principal Advisor
-
2017
Doctor Philosophy
Characterisation of Factors Involved in Escherichia coli Virulence: Type Ve Inverse Autotransporter Proteins and the K1 Capsule
Principal Advisor
-
2016
Master Philosophy
Autotransporter Proteins of Uropathogenic Escherichia coli: Regulation, Characterisation and the Role of Periplasmic Proteins in their Expression
Principal Advisor
-
2016
Doctor Philosophy
Uropathogenic Escherichia coli: Towards a Better Understanding through the Characterisation of a Vaccine Antigen and Virulence Factor
Principal Advisor
-
2014
Doctor Philosophy
Evolutionary Phylogeny and Molecular Characterisation of Chaperone-Usher Fimbriae from Uropathogenic Escherichia coli
Principal Advisor
-
2014
Doctor Philosophy
Investigating the Virulence Potential of the Multidrug Resistant Uropathogenic Escherichia coli ST131 clone
Principal Advisor
Other advisors: Associate Professor Scott Beatson
-
2012
Doctor Philosophy
Molecular analysis of Acinetobacter baumannii isolates from an intensive care unit
Principal Advisor
Other advisors: Associate Professor Scott Beatson
-
2011
Doctor Philosophy
Identification and Characterisation of New Adhesins in Uropathogenic Escherichia coli
Principal Advisor
-
2011
Doctor Philosophy
Molecular characterisation of asymptomatic bacteriuria Escherichia coli
Principal Advisor
-
2011
Doctor Philosophy
Identification and characterisation of novel surface proteins of the urinary tract pathogen Staphylococcus saprophyticus
Principal Advisor
Other advisors: Associate Professor Scott Beatson
-
2009
Doctor Philosophy
Identification and Characterisation of Novel Autotransporters of Enterohaemorrhagic Escherichia coli O157:H7
Principal Advisor
-
2009
Doctor Philosophy
Bacterial Aggregation and Biofilm Formation by Uropathogenic Escherichia coli
Principal Advisor
-
2024
Master Philosophy
Theoretical investigations of integron evolution in bacteria
Associate Advisor
Other advisors: Associate Professor Jan Engelstaedter
-
2024
Doctor Philosophy
Application of Transposon Directed Insertion Site Sequencing to Enhance Understanding of Essential Genes in Escherichia coli
Associate Advisor
Other advisors: Professor Ian Henderson
-
2023
Doctor Philosophy
Characterisation of the macrophage zinc toxicity response as an antimicrobial weapon
Associate Advisor
Other advisors: Professor Matt Sweet
-
2022
Doctor Philosophy
A bitter taste in your heart: the role of T2Rs in cardiovascular physiology and pathophysiology
Associate Advisor
Other advisors: Professor Mark Walker, Professor Wally Thomas
-
2022
Doctor Philosophy
Understanding Roles of Commonly Prescribed Antidepressants in the Dissemination of Antibiotic Resistance
Associate Advisor
Other advisors: Professor Jianhua Guo
-
2021
Doctor Philosophy
Characterising B1 Metallo-ß-Lactamases (MBLs)
Joint Principal Advisor
Other advisors: Professor Gary Schenk
-
2019
Doctor Philosophy
Investigation of innate immune antimicrobial zinc toxicity
Associate Advisor
Other advisors: Professor Matt Sweet
-
2019
Doctor Philosophy
Characterization of interactions between uropathogenic Escherichia coli and the innate immune system
Associate Advisor
Other advisors: Professor Matt Sweet
-
2019
Doctor Philosophy
Application of whole genome sequencing to characterise clinically significant multidrug resistant bacteria
Associate Advisor
Other advisors: Associate Professor Scott Beatson
-
2017
Doctor Philosophy
Bacterial ketol-acid reductoisomerase: structure, catalytic mechanism and thermal stability
Associate Advisor
Other advisors: Professor Bostjan Kobe, Professor Luke Guddat
-
2016
Doctor Philosophy
Preventing canine urinary tract infection (UTI) using an asymptomatic bacteriuria (ASB) Escherichia coli strain
Associate Advisor
Other advisors: Professor Paul Mills
-
2015
Doctor Philosophy
Investigating the host and bacterial factors in cystic fibrosis that promote persistence of infection in the lung.
Associate Advisor
-
2014
Doctor Philosophy
Structural and functional studies of TcpB, a protein involved in Brucella pathogenesis
Associate Advisor
Other advisors: Professor Matt Sweet, Professor Bostjan Kobe
-
2014
Doctor Philosophy
Structural & Functional Characterization of Bacterial TRX-fold proteins
Associate Advisor
Other advisors: Emerita Professor Jenny Martin
-
2013
Doctor Philosophy
Identification and characterization of anti-microbial pathways in human macrophages
Associate Advisor
Other advisors: Professor Kate Stacey, Professor Matt Sweet
-
2007
Doctor Philosophy
FUNCTIONAL CHARACTERISATION OF THE MULTICOPPER OXIDASE FROM Escherichia coli and Salmonella typhimurium
Associate Advisor
Media
Enquiries
For media enquiries about Professor Mark Schembri's areas of expertise, story ideas and help finding experts, contact our Media team: